News
District hospitals key to unlocking Global South surgical conundrum
Patients attending first referral hospitals in low- and middle-income countries (LMICs) receive surgical care that is just as safe and effective as that provided by higher level referral centres, a new study reveals. Researchers found no significant difference in 30-day...
Ciliatech appoints world-class panel of eyecare specialists to newly created KOL advisory board
Ciliatech will leverage ophthalmic expertise of seven-member advisory board to bring to market Intercil® Uveal Spacer, a novel glaucoma implant offering unique benefits to eye surgeons and patients across the globe Ciliatech, an innovative medtech company focusing on the treatment...
Booster accelerates EU-funded projects results to create tangible impact
META Group is proud to announce that Booster has been renewed for another four years, with additional and customised services. Funded by the European Commission’s Directorate-General for Research and Innovation (DG RTD) and led by META Group, Booster offers a...
£1 million gift towards world-leading new centre for advancing eye health to enhance education
The Schroder Foundation and Family have donated £1 million to Moorfields Eye Charity towards the new centre for advancing eye health. The building is under construction and opening in 2027. Oriel is a joint initiative between Moorfields Eye Hospital NHS...
College of Optometrists welcomes over 500 new optometrists to the profession at the 2024 Diploma Ceremonies
Last week, the College of Optometrists welcomed over 500 new optometrists to the profession in two College Diploma Ceremonies in Westminster on 12 November 2024, where new members were joined by their family, friends and peers. The ceremonies took place...
Research into headlight glare commissioned by government
The government has commissioned much needed research into the causes of night-time headlight glare, after campaigning involving the College of Optometrists among others. The College spearheaded the lobbying on behalf of the optical sector, in collaboration with colleagues from the...
The Worshipful Company of Spectacle Makers rewards early career research
The Worshipful Company of Spectacle Makers (WCSM) this week announced the winners of its annual bronze medal award competitions for vision research. Both the winning submissions demonstrated models for earlier diagnosis of significant eye disease and have the capacity to...
Vision for the future: Changes to Glaucoma UK’s research programme in 2025
Glaucoma UK is excited to announce a new, reshaped Research Grants Programme for 2025. Set to open in January, this programme aims to support innovative research to improve the understanding, treatment, and care of glaucoma. Alongside opportunities for researchers at...
Glaucoma UK and the Royal College of Ophthalmologists announce the 2024 research award winners
Glaucoma UK and the Royal College of Ophthalmologists are delighted to announce the winners of the 2024 Glaucoma UK/RCOphth Research Award. As a result of the high quality of applications received, the judging panel have awarded two projects, worth nearly...
ABDO announces groundbreaking therapy for contact lens opticians
The Association of British Dispensing Opticians (ABDO) has given the go ahead for contact lens opticians to prescribe a groundbreaking new therapy, enabling ~1,700 new practitioners to offer the treatment to their patients. NuVision Biotherapies, a UK based tissue-therapy company...
HOYA Vision Care’s Defocus Incorporated Multiple Segments Spectacle Lenses demonstrated significant trend of myopia control in children
Interim analysis from the Observational French Study in children presented at EPOS 2024 meeting in Paris. Data from an interim analysis of the Observational French Study, OPHTAMYOP, has demonstrated a significant trend of myopia control in children with spherical equivalent...
New study uncovers key mechanism behind a common genetic cause of age-related visual loss
A groundbreaking study has revealed important insights into the mechanisms behind Fuchs Endothelial Corneal Dystrophy (FECD), a common cause of age-related visual loss, providing hope for future therapeutic developments, and finding implications for other neurological diseases. FECD is a common,...
